Senator Ron Wyden (D-Ore.), a senior member of the Senate Finance Committee, accused Pfizer (PFE) of carrying out what he ...
Wall Street edged lower after getting pulled in opposite directions as President Donald Trump’s latest tariff escalation creates winners and losers among auto stocks. The S&P 500 slipped 0.3% Thursday ...
Pfizer (PFE) faces allegations from Senator Ron Wyden (D-Ore.) of running the largest tax-avoidance scheme in Big Pharma.
Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...
Citi analyst Geoff Meacham keeps a Neutral rating on Pfizer (PFE) with a $27 price target after the Wall Street Journal reported that U.S.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals ...
Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...
Stocks rose in morning trading as Wall Street navigates through uncertainty amid a trade war. The S&P 500 jumped 1.1%. It is ...